Empire Life Investments Inc. has recently submitted its 13F-HR report, detailing its investment holdings as of September 30, 2026. This filing is crucial as it provides insights into the company's investment strategies and positions in the market. The report reveals a diverse portfolio, indicating Empire Life's strategic approach to asset management.

Background

Empire Life Investments Inc. is a financial services company based in Toronto, Canada. It specializes in investment management and asset allocation strategies. The company is not publicly traded and operates under the Central Index Key (CIK) number 0001640951. The latest filing, dated November 6, 2026, is part of a series of reports that the company has submitted, including several 13F-HR forms throughout the year.

What the Filing Says

The 13F-HR filing reveals that Empire Life Investments holds a total of 108 different positions, with a total value of approximately $1.83 billion. Notable companies in their portfolio include Advanced Micro Devices Inc., Alnylam Pharmaceuticals Inc., and Alphabet Inc. The report states, "The total value of the holdings is $1,825,895,369," showcasing the scale of Empire Life's investment activities.

Impact

This filing may affect various stakeholders, including investors, analysts, and competitors in the investment management industry. The detailed insights into Empire Life's holdings provide a benchmark for other firms in the sector. Competitors may analyze these positions to gauge market trends and adjust their strategies accordingly.

What's Next

The filing does not specify what happens next regarding Empire Life's investment strategies or any upcoming votes related to their holdings. Investors and analysts will likely watch for future filings to see how the company adjusts its portfolio in response to market conditions.